Why the study?
Does intravenous nadolol increase renal blood flow in hypertensive patients and healthy volunteers?
Does intravenous nadolol increase renal blood flow in hypertensive patients and healthy volunteers?
Intravenous nadolol significantly increases renal blood flow and decreases heart rate and plasma renin activity, contrasting with the effects of other beta-blockers.
No takes yet. Share an insight, caveat, or question.
Challenges class effects of beta-blockers on renal flow; leaves open clinical relevance in hypertension.
Nk et al. (1979) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: